Public combat over US drug prices centers on Prop 61 as rhetoric heats up to fever pitch
A week ago, Proposition 61 looked like a sure winner for its advocates. With sentiment running strongly against Big Pharma companies, polls showed plenty of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
